CD8A and small cell lung carcinoma: Notably, the prediction of prognosis was aided by the analysis of a small fraction of samples obtained from heterogeneous tumors and CD8 immunostaining, which is used in daily diagnostic practice, even without antibodies, for determining the IHC subtype of SCLC.